Hemant Kumar Daima

Hemant Kumar Daima

Auto-generated profile, based on publicly available information

Hemant Kumar Daima

Nanomedicine and Nanotoxicity Research Laboratory, Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, NH-8, Bandarsindari, Kishangarh, Ajmer 305817, India; Department of Health Sciences, Interdisciplinary School of Health Sciences, Central University of Rajasthan, NH-8, Bandarsindari, Kishangarh, Ajmer 305817, India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2019 in Nano Convergence
Verified
Journal Article
Open access
PDF file
PNP. N. Navya
P. N. Navya
AKAnubhav Kaphle
Anubhav Kaphle
SSS. P. Srinivas
S. P. Srinivas
SBSuresh K. Bhargava
Suresh K. Bhargava
VRVincent M. Rotello
Vincent M. Rotello
HDHemant Kumar Daima
Hemant Kumar Daima
Nanotechnology has the potential to circumvent several drawbacks of conventional therapeutic formulations. In fact, significant strides have been made towards the application of engineered nanomaterials for the treatment of cancer with high specificity, sensitivity and efficacy. Tailor-made nanomaterials functionalized with specific ligands can target cancer cells in a predictable manner and deliver encapsulated payloads effectively. Moreover, nanomaterials can also be designed for increased drug loading, improved half-life in the body, controlled release, and selective distribution by modifying their composition, size, morphology, and surface chemistry. To date, polymeric nanomaterials, metallic nanoparticles, carbon-based materials, liposomes, and dendrimers have been developed as smart drug delivery systems for cancer treatment, demonstrating enhanced pharmacokinetic and pharmacodynamic profiles over conventional formulations due to their nanoscale size and unique physicochemical characteristics. The data present in the literature suggest that nanotechnology will provide next-generation platforms for cancer management and anticancer therapy. Therefore, in this critical review, we summarize a range of nanomaterials which are currently being employed for anticancer therapies and discuss the fundamental role of their physicochemical properties in cancer management. We further elaborate on the topical progress made to date toward nanomaterial engineering for cancer therapy, including current strategies for drug targeting and release for efficient cancer administration. We also discuss issues of nanotoxicity, which is an often-neglected feature of nanotechnology. Finally, we attempt to summarize the current challenges in nanotherapeutics and provide an outlook on the future of this important field.

1 February 2016 in Nano Convergence
Verified
Journal Article
Open access
PDF file
PNP. N. Navya
P. N. Navya
HDHemant Kumar Daima
Hemant Kumar Daima
Innovative engineered nanomaterials are at the leading edge of rapidly emerging fields of nanobiotechnology and nanomedicine. Meticulous synthesis, unique physicochemical properties, manifestation of chemical or biological moieties on the surface of materials make engineered nanostructures suitable for a variety of biomedical applications. Besides, tailored nanomaterials exhibit entirely novel therapeutic applications with better functionality, sensitivity, efficiency and specificity due to their customized unique physicochemical and surface properties. Additionally, such designer made nanomaterials has potential to generate series of interactions with various biological entities including DNA, proteins, membranes, cells and organelles at nano-bio interface. These nano-bio interactions are driven by colloidal forces and predominantly depend on the dynamic physicochemical and surface properties of nanomaterials. Nevertheless, recent development and atomic scale tailoring of various physical, chemical and surface properties of nanomaterials is promising to dictate their interaction in anticipated manner with biological entities for biomedical applications. As a result, rationally designed nanomaterials are in extensive demand for bio-molecular detection and diagnostics, therapeutics, drug and gene delivery, fluorescent labelling, tissue engineering, biochemical sensing and other pharmaceuticals applications. However, toxicity and risk associated with engineered nanomaterials is rather unclear or not well understood; which is gaining considerable attention and the field of nanotoxicology is evolving promptly. Therefore, this review explores current knowledge of articulate engineering of nanomaterials for biomedical applications with special attention on potential toxicological perspectives.

29 August 2017 in Environmental Chemistry Letters
Verified
Journal Article
Closed access
PDF file
AKAnubhav Kaphle
Anubhav Kaphle
PNP. N. Navya
P. N. Navya
AUAkhela Umapathi
Akhela Umapathi
HDHemant Kumar Daima
Hemant Kumar Daima

6 October 2014 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
TSTARUN SHARMA
TARUN SHARMA
Rajesh RamanathanRajesh Ramanathan
Rajesh Ramanathan
PWPabudi Weerathunge
Pabudi Weerathunge
MMMahsa Mohammadtaheri
Mahsa Mohammadtaheri
HDHemant Kumar Daima
Hemant Kumar Daima
VBVipul Bansal
Vipul Bansal
A new ultrafast and highly sensitive ‘turn-off/turn-on’ biosensing approach that combines the intrinsic peroxidase-like activity of gold nanoparticles (GNPs) with the high affinity and specificity of a ssDNA aptamer is presented.

24 September 2013 in Nanoscale
Verified
Journal Article
Closed access
PDF file
HDHemant K. Daima
Hemant K. Daima
PSP. R. Selvakannan
P. R. Selvakannan
AKAhmad E. Kandjani
Ahmad E. Kandjani
RSRavi Shukla
Ravi Shukla
SBSuresh K. Bhargava
Suresh K. Bhargava
VBVipul Bansal
Vipul Bansal
We illustrate a new strategy to improve the antibacterial potential of silver nanoparticles (AgNPs) by their surface modification with the surface corona of biologically active polyoxometalates (POMs). The stable POM surface corona was achieved by utilising zwitterionic tyrosine amino acid as a pH-switchable reducing and capping agent of AgNPs. The general applicability of this approach was demonstrated by developing surface coronas of phosphotungstic acid (PTA) and phosphomolybdic acid (PMA) around AgNPs. Our investigations on Gram negative bacterium Escherichia coli demonstrate that in conjugation with AgNPs, the surface corona of POMs enhances the physical damage to the bacterial cells due to synergistic antibacterial action of AgNPs and POMs, and the ability of tyrosine-reduced AgNPs (AgNPsY) to act as an excellent carrier and stabiliser for the POMs. The further extension of this study towards Gram positive bacterium Staphylococcus albus showed a similar toxicity pattern, whereas these nanomaterials were found to be biocompatible for PC3 epithelial mammalian cells, suggesting the potential of these materials towards specific antimicrobial targeting for topical wound healing applications. The outcomes of this work show that facile tailorability of nanostructured surfaces may play a considerable role in controlling the biological activities of different nanomaterials.

13 September 2022 in Science of The Total Environment
Verified
Journal Article
Closed access
RSRagini Singh
Ragini Singh
AUAkhela Umapathi
Akhela Umapathi
GPGaurang Patel
Gaurang Patel
CPChayan Patra
Chayan Patra
UMUzma Malik
Uzma Malik
HDHemant Kumar Daima
Hemant Kumar Daima